Artificial intelligence in anti-infectives
23 May 2025 at 11.00 CET*
Artificial intelligence (AI) can support antimicrobial treatment decisions by rapidly analysing large volumes of patient data, laboratory results, and local resistance patterns to recommend the most effective and targeted antibiotics. By integrating real-time information from electronic health records, AI can help clinicians choose optimal treatments while avoiding unnecessary or broad-spectrum antibiotic use. Additionally, AI systems can detect emerging trends in antimicrobial resistance, allowing for early intervention and improved infection control measures. This contributes to better stewardship of existing antibiotics and helps prevent the spread of resistant pathogens in both healthcare settings and the community”. Our two eminent speakers provide real and timely intelligence on how much of this is possible now, what we may expect in the future, and how humans should use AI tools.
* Find your start time by time zone
** Certificates of attendance are available for those attending the majority of the webinar.
PROGRAMME
Tracking antibiotic resistance with artificial intelligence
Adrian Egli
Optimising antibiotic use with model-informed precision dosing
Sebastian Wicha
SPEAKER BIOS
Prof. Adrian Egli is the chair of medical microbiology and the director of the Institute of Medical Microbiology at the University of Zurich, Switzerland. His research focuses on host-pathogen interaction and studying how AMR and virulence evolves. For this he uses different -omics techniques and bioinformatics and machine learning techniques for data analysis.
Prof. Sebastian Wicha is a leading the research group Clinical Pharmacy at the Institute of Pharmacy, University of Hamburg, Germany. His research group aims to improve and individualize drug therapy by means of pharmacokinetic-pharmacodynamic and pharmacometric techniques with a special focus on anti-infectives. In this field, he has published >90 peer-reviewed papers. His research group has expertise in bioanalysis, pharmacometric data analysis, and develops open-access web-based software to foster model-informed precision dosing (TDMx.eu). Sebastian is Associate Editor at the International Journal of Antimicrobial Agents (IJAA), and served as President (term 2020-2022) of the International Society of Anti-Infective Pharmacology (ISAP) and since 2019 as Education officer of the PK/PD study group of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID). He is an external expert for pharmacometrics for the German Federal Institute for Drugs and Medical Devices (BfArM) and the European Medicines Agency (EMA).
Dr David Jenkins is a consultant medical microbiologist at University Hospitals of Leicester NHS Trust, where he has been the infection prevention lead doctor for the last 25 years as well as antimicrobial stewardship lead. He is also an honorary associate professor at Leicester University and, between 2021-2024, the president of the British Society for Antimicrobial Chemotherapy. His interests include behavioural aspects of antimicrobial prescribing and stewardship as well as data analysis and policy development. Prof. Jenkins is ISAC's Treasurer.
Prof. Marco Falcone serves as a Full Professor in the Department of Clinical and Experimental Medicine at the University of Pisa, Italy. His research primarily focuses on the clinical and molecular epidemiology of infections caused by multi-drug resistant organisms, aiming to translate this knowledge into effective prevention and treatment strategies. Prof. Falcone has published over 230 indexed articles in leading journals, with a H-index of 58 and about 13.000 citations. He has also been a principal investigator in numerous national and international clinical studies on anti-infective agents. His contributions to the field have earned him several accolades, including the Infectious Diseases Society of America's Emanuel Wolinsky Award.
In addition to his academic and research roles, Prof. Falcone is actively involved in various professional organizations. He is a member of the board of the Italian Society of Infectious Diseases, treasurer of the ESCMID study group for infections in the elderly (ESGIE), and ESCMID Fellow (FESCMID). He is also a member of the ISAC Executive Committee.
